Tekmira Stops Testing Ebola Drug In Sierra Leone

Tekmira Pharmaceuticals Corporation said that it will discontinue the clinical trial of its experimental Ebola drug known as TKM-Ebola-Guinea after reaching a statistical futility boundary. The company concluded that it is unsure whether the treatment helped anyone during the testing.
Real Time Analytics